Hello Community,

I'm contacting you here because I can't get rid of a topic. It's somehow not that dramatic, but since I like to have things in order (especially statistics ;)) I keep thinking about it.

First of all: I have my securities account with ING. At the time of the demerger/reverse split of $GSK (+1,28 %) (old) were held. As expected, these were then supplemented by $HLN (-0,02 %) shares in the same quantity as expected and then the GSK shares were $GSK (+1,28 %) shares at a ratio of 5:4.

So far so good. But now GSK has taken the purchase value of the old GSK shares and simply split them 50/50. This means that I have a nonsensically low purchase value on the new GSK shares (and am correspondingly strongly in the plus) and with the Haleon shares I have a nonsensically high purchase value, well above what was ever possible with the share.

Of course, it's great that if Haleon develops positively, I won't have to pay any tax on this increase in value when I sell. But if I sell GSK, I'll be asked to pay a hefty tax as the share is up almost 60%. Doesn't feel right.

To make it perfect, this didn't happen analogously with Getquin... But that could also be due to the fact that ING first billed differently, then canceled it and then split it up as discussed...

So now the question is, how were the acquisition values divided up for you?